Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSULET CORP Director's Dealing 2021

Jul 2, 2021

30258_dirs_2021-07-02_5327e1a7-a845-4645-adfe-292e0ddfbb73.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSULET CORP (PODD)
CIK: 0001145197
Period of Report: 2021-05-14

Reporting Person: Petrovic Shacey (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-14 Common Stock G 25905 Disposed 15684 Direct
2021-05-14 Common Stock G 25905 Acquired 25905 Indirect
2021-07-01 Common Stock M 15000 $30.58 Acquired 30779 Direct
2021-07-01 Common Stock S 15000 $278.56 Disposed 15779 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-07-01 Employee Stock Option (Right to Buy) $30.58 M 15000 Disposed 2025-02-09 Common Stock (15000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 87495 Indirect

Footnotes

F1: On May 14, 2021, the reporting person gifted 25,905 shares of Insulet common stock to a family trust of which the reporting person is the settlor and a trustee. The beneficiaries of the trust are members of the reporting person's immediate family.

F2: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

F3: Includes 95 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 28, 2021.

F4: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $274.695 to $280.55. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F5: This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.